Christina Koop

Hamburg, HH 20246, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.

Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.

Journal: Cancer cell

Published: May 26, 2018

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.

Journal: BMC cancer

Published: March 07, 2018

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer.

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer.

Journal: European urology

Published: October 16, 2017

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.

Journal: Oncotarget

Published: April 04, 2017

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.

Journal: BJU international

Published: March 16, 2017

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Journal: Oncotarget

Published: February 02, 2017

MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.

MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.

Journal: Journal of mass spectrometry : JMS

Published: October 12, 2016

βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer.

βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer.

Journal: Human pathology

Published: August 15, 2016

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.

Journal: Oncotarget

Published: May 04, 2016

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 30, 2016

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.

Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.

Journal: Carcinogenesis

Published: July 08, 2015

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Journal: Oncotarget

Published: May 27, 2015

Showing 1-12 of 35

Last Updated: 09/26/2026